Back to search results

Treatment for Self-Injurious Behaviors in Veterans

This study is looking at a treatment called T-SIB (Treatment for Self-Injurious Behaviors) for veterans who have engaged in nonsuicidal self-injury (NSSI). NSSI is when someone intentionally harms their body without intending to die. The study aims to see if T-SIB can help reduce NSSI and improve overall well-being. You might be able to join if you are a veteran, 18 or older, have engaged in NSSI at least twice in the past 30 days, and can speak English. The study will enroll 40 participants and will measure how many people join and stay in the study as a sign of its success. The current recruitment status is unclear.

Study design
This is an interventional study with 40 participants. You would be randomly assigned to either receive T-SIB or Treatment As Usual.
What's involved
Treatment lasts about nine weeks. The study will measure how many people stay in the study at the end of treatment.
Compensation
Not stated in the trial record.
Follow-up
The study measures how many participants stay in the study at the end of treatment, which is about nine weeks after starting.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05969080

Self-Injury Treatment and Recovery in Veterans

Recruiting
NAAges 18+InterventionalTreatment
VA Office of Research and Development
~40 participants
Updated 2026-02-19 on ClinicalTrials.gov
What's tested:Treatment for Self-Injurious BehaviorsTreatment As Usual

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility as measured by number of participants enrolled
Measured over 2 years after study enrollment begins
+1 more outcome measured

Conditions

Self-Injurious Behavior

Explore related trials

Self-injurious behavior

Where it's being run

1 sites across 1 states
North Carolina1

Study leadership

  • Tate F Halverson, PhD · PRINCIPAL_INVESTIGATOR · Durham VA Medical Center, Durham, NC

Who to contact

Tate F Halverson, PhD
[email protected]
(919) 286-0411 · ext. 175415
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

18 years of age or older
Past service in the United States military
Nonsuicidal self-injury engagement on 2 occasions in past 30 days
Fluent in English
Able to provide voluntary informed consent

Exclusion

Lifetime history of psychosis, mania, or hypomania
Imminent risk for suicide/homicide warranting immediate intervention
Unable/unwilling to complete study procedures

What this trial measures

  • Feasibility as measured by number of participants enrolled2 years after study enrollment begins

    All participants (N = 40) will need to be enrolled by the end of the second year of the study to consider the recruitment benchmark met.

  • Feasibility as measured rate of retentionEnd of treatment, about nine weeks after beginning the study

    Retention will be measured by the number of participants who complete at least six T-SIB treatment sessions. This benchmark will be considered meet if at least 2/3 of the 20 participants randomized to T-SIB complete at least 6 treatment sessions.